IL1B and COVID-19: Severe COVID-19 is characterized by a marked hyperinflammatory response resulting in a cytokine storm, with dysregulated production of proinflammatory cytokines (e.g., IL-1β and IL-6), resulting in significant lymphopenia, C-reactive protein increase, and a profound vascular dysfunction.